Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tg Therapeutics (NQ: TGTX )

23.48 -0.35 (-1.47%)
Streaming Delayed Price Updated: 3:30 PM EDT, Sep 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,410,315
Open 23.74
Bid (Size) 23.47 (3)
Ask (Size) 23.49 (2)
Prev. Close 23.83
Today's Range 23.32 - 24.40
52wk Range 6.460 - 26.41
Shares Outstanding 154,420,772
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unlocking the Growth Potential of NASDAQ:TGTX.
TG THERAPEUTICS INC (NASDAQ:TGTX) may be suited for growth investing, we'll explore why in this article. 
Via Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga

Performance

YTD
+37.79%
+37.79%
1 Month
-0.04%
-0.04%
3 Month
+29.37%
+29.37%
6 Month
+58.97%
+58.97%
1 Year
+187.75%
+187.75%

More News

Read More
Stock Market Hits Record Highs On Big Fed Rate Cut; Apple, Intel, FedEx In Focus: Weekly Review
Via Investor's Business Daily
Topics Economy
Exposures Interest Rates
Evaluating TG Therapeutics: Insights From 4 Financial Analysts
Via Benzinga
What's Going On With TG Therapeutics Stock Wednesday?
Via Benzinga
Why NASDAQ:TGTX is Poised for High Growth.
Via Chartmill
In the world of growth stocks, NASDAQ:TGTX shines as a value proposition.
Via Chartmill
Decoding TG Therapeutics's Options Activity: What's the Big Picture?
Via Benzinga
Why the growth investor may take a look at NASDAQ:TGTX.
Via Chartmill
IBD 50's TG Therapeutics Surges On Five-Year Data For Multiple Sclerosis Drug
Via Investor's Business Daily
Despite its growth, NASDAQ:TGTX remains within the realm of affordability.
Via Chartmill
NASDAQ:TGTX—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
Via Chartmill
What's Going On With ADMA Biologics Stock Monday?
Via Benzinga
Topics Stocks
Exposures US Equities
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
A Closer Look at TG Therapeutics's Options Market Dynamics
Via Benzinga
NASDAQ:TGTX: a strong growth stock preparing for the next leg up?.
Via Chartmill
IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter
Via Investor's Business Daily
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
Via Benzinga
Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review
Via Investor's Business Daily
NASDAQ:TGTX is showing decent growth, but is still valued reasonably.
Via Chartmill
S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimates
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
Crude Oil Moves Higher; Yum! Brands Posts Upbeat Earnings
Via Benzinga
Exposures Fossil Fuels
TGTX Stock Earnings: TG Therapeutics Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
TG Therapeutics Stock Jumps As Surprise Profit Smashes Views By 157%
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS